Entering text into the input field will update the search result below

Medtronic wins FDA approval for Vanta neurostimulator

Jun. 10, 2021 9:29 AM ETMedtronic plc (MDT) StockMDTBy: Dulan Lokuwithana, SA News Editor

Medtronic at Canada Headquarters in Brampton, Ontario, Canada.
JHVEPhoto/iStock Editorial via Getty Images

  • Medtronic (NYSE:MDT) has announced that the FDA has approved Vanta, its recharge-free implantable neurostimulator (INS).
  • With a device life that can be optimized up to 11 years, Vanta can offer nearly twice the device life compared to

Recommended For You

More Trending News

About MDT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MDT--
Medtronic plc